Analysts are more bearish after recent results, with a signi...

Analysts are more bearish after recent results, with a significant cut to EPS estimates. They expect Herbalife's revenue growth to slow down substantially, with revenues to the end of 2024 expected to display 0.5% growth annually, compared to a historical growth rate of 1.3% over the past five years. The analysts also cut their price targets, indicating increased pessimism about the business's intrinsic value.